Treatment with etanercept (Enbrel) beyond 10 years is safe and effective for patients with early and long-standing rheumatoid arthritis (RA), according to findings published in the October 18th online Arthritis Care & Research. Reuters Health Information
Patients with rheumatoid arthritis demonstrate general hyperalgesia to mechanical and thermal stimuli across several body sites. Reuters Health Information
Disease-modifying anti-rheumatic drugs are as effective as the biologic agent etanercept plus methotrexate for the treatment of early aggressive rheumatoid arthritis. Medscape Medical News
Although many patients with juvenile idiopathic arthritis have a low level of disease, about 20% have moderate to severe disability, Italian researchers report in the November 15th issue of Arthritis & Rheumatism. Reuters Health Information
The endothelin receptor antagonist bosentan is ineffective for interstitial lung disease due to systemic sclerosis, according to new data. Reuters Health Information
